Bio equivalency test scandal no affected to drug wholesalers.

Published: 2006-05-01 06:59:00

Updated: 2006-05-01 06:59:00

10 drug companies had admitted the KFDA's investigation report on the bio equivalency test manipulation, which raised an overall catastrophic consequence to all drug industries, However, it did not give a serious impact to the drug wholesale business except Alrendronic acid preparations.

The w...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK